These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
471 related articles for article (PubMed ID: 21368175)
1. Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells. Antonyak MA; Li B; Boroughs LK; Johnson JL; Druso JE; Bryant KL; Holowka DA; Cerione RA Proc Natl Acad Sci U S A; 2011 Mar; 108(12):4852-7. PubMed ID: 21368175 [TBL] [Abstract][Full Text] [Related]
2. A novel RGD-independent cel adhesion pathway mediated by fibronectin-bound tissue transglutaminase rescues cells from anoikis. Verderio EA; Telci D; Okoye A; Melino G; Griffin M J Biol Chem; 2003 Oct; 278(43):42604-14. PubMed ID: 12732629 [TBL] [Abstract][Full Text] [Related]
3. RhoA triggers a specific signaling pathway that generates transforming microvesicles in cancer cells. Li B; Antonyak MA; Zhang J; Cerione RA Oncogene; 2012 Nov; 31(45):4740-9. PubMed ID: 22266864 [TBL] [Abstract][Full Text] [Related]
4. Microvesicle Cargo and Function Changes upon Induction of Cellular Transformation. Kreger BT; Dougherty AL; Greene KS; Cerione RA; Antonyak MA J Biol Chem; 2016 Sep; 291(38):19774-85. PubMed ID: 27440046 [TBL] [Abstract][Full Text] [Related]
5. TGF-beta2-induced cell surface tissue transglutaminase increases adhesion and migration of RPE cells on fibronectin through the gelatin-binding domain. Priglinger SG; Alge CS; Neubauer AS; Kristin N; Hirneiss C; Eibl K; Kampik A; Welge-Lussen U Invest Ophthalmol Vis Sci; 2004 Mar; 45(3):955-63. PubMed ID: 14985317 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of transglutaminase activity reduces extracellular matrix accumulation induced by high glucose levels in proximal tubular epithelial cells. Skill NJ; Johnson TS; Coutts IG; Saint RE; Fisher M; Huang L; El Nahas AM; Collighan RJ; Griffin M J Biol Chem; 2004 Nov; 279(46):47754-62. PubMed ID: 15326185 [TBL] [Abstract][Full Text] [Related]
7. Cell surface localization of tissue transglutaminase is dependent on a fibronectin-binding site in its N-terminal beta-sandwich domain. Gaudry CA; Verderio E; Aeschlimann D; Cox A; Smith C; Griffin M J Biol Chem; 1999 Oct; 274(43):30707-14. PubMed ID: 10521459 [TBL] [Abstract][Full Text] [Related]
8. A unique role for heat shock protein 70 and its binding partner tissue transglutaminase in cancer cell migration. Boroughs LK; Antonyak MA; Johnson JL; Cerione RA J Biol Chem; 2011 Oct; 286(43):37094-107. PubMed ID: 21896482 [TBL] [Abstract][Full Text] [Related]
9. Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin. Akimov SS; Belkin AM Blood; 2001 Sep; 98(5):1567-76. PubMed ID: 11520809 [TBL] [Abstract][Full Text] [Related]
10. EGF potentiated oncogenesis requires a tissue transglutaminase-dependent signaling pathway leading to Src activation. Li B; Antonyak MA; Druso JE; Cheng L; Nikitin AY; Cerione RA Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1408-13. PubMed ID: 20080707 [TBL] [Abstract][Full Text] [Related]
11. Potential role for high and low molecular weight tissue transglutaminases in transforming mammalian cell properties. Mezzogiorno A; Esposito V Curr Drug Targets Immune Endocr Metabol Disord; 2001 Nov; 1(3):223-32. PubMed ID: 12477288 [TBL] [Abstract][Full Text] [Related]
12. Triple-negative breast cancer-derived microvesicles transfer microRNA221 to the recipient cells and thereby promote epithelial-to-mesenchymal transition. Das K; Paul S; Singh A; Ghosh A; Roy A; Ansari SA; Prasad R; Mukherjee A; Sen P J Biol Chem; 2019 Sep; 294(37):13681-13696. PubMed ID: 31341019 [TBL] [Abstract][Full Text] [Related]
13. The Different Conformational States of Tissue Transglutaminase Have Opposing Affects on Cell Viability. Singh G; Zhang J; Ma Y; Cerione RA; Antonyak MA J Biol Chem; 2016 Apr; 291(17):9119-32. PubMed ID: 26893378 [TBL] [Abstract][Full Text] [Related]
14. Proteomic profiling of human embryonic stem cell-derived microvesicles reveals a risk of transfer of proteins of bovine and mouse origin. Kubikova I; Konecna H; Sedo O; Zdrahal Z; Rehulka P; Hribkova H; Rehulkova H; Hampl A; Chmelik J; Dvorak P Cytotherapy; 2009; 11(3):330-40, 1 p following 340. PubMed ID: 19401887 [TBL] [Abstract][Full Text] [Related]
15. RGD-independent cell adhesion via a tissue transglutaminase-fibronectin matrix promotes fibronectin fibril deposition and requires syndecan-4/2 α5β1 integrin co-signaling. Wang Z; Collighan RJ; Gross SR; Danen EH; Orend G; Telci D; Griffin M J Biol Chem; 2010 Dec; 285(51):40212-29. PubMed ID: 20929862 [TBL] [Abstract][Full Text] [Related]
16. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity. de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696 [TBL] [Abstract][Full Text] [Related]
17. Cell surface transglutaminase promotes RhoA activation via integrin clustering and suppression of the Src-p190RhoGAP signaling pathway. Janiak A; Zemskov EA; Belkin AM Mol Biol Cell; 2006 Apr; 17(4):1606-19. PubMed ID: 16452636 [TBL] [Abstract][Full Text] [Related]
18. Regulation of platelet-derived growth factor receptor function by integrin-associated cell surface transglutaminase. Zemskov EA; Loukinova E; Mikhailenko I; Coleman RA; Strickland DK; Belkin AM J Biol Chem; 2009 Jun; 284(24):16693-16703. PubMed ID: 19386600 [TBL] [Abstract][Full Text] [Related]